DexCom Inc/ US2521311074 /
21/05/2024 20:54:22 | Chg. -0.0900 | Volume | Bid21/05/2024 | Ask21/05/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
130.6000USD | -0.07% | 698,929 Turnover: 52.42 mill. |
130.5700Bid Size: 100 | 130.6300Ask Size: 200 | 51.89 bill.USD | - | 93.19 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 1.40 USD | 59.09% |
EPS Diluted: | 1.30 USD | 58.54% |
Revenues per Share: | 9.40 USD | 24.78% |
Book Value per Share: | 5.37 USD | -2.74% |
Cash Flow per Share: | 1.94 USD | 12.06% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 3,622.30 USD | 24.49% |
Net Income: | 541.50 USD | 58.70% |
Operating Cash Flow: | 748.50 USD | - |
Cash and Cash Equivalents: | 566.30 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 93.19 | 88.64 |
P/S Ratio: | 13.89 | 13.21 |
P/BV ratio: | 24.32 | 23.13 |
P/CF Ratio: | 67.20 | 63.91 |
PEG: | 1.58 | 1.50 |
Earnings Yield: | 1.07% | 1.13% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 51.89 bill. USD | 47.84 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 397.68 mill. |
Profitability
Gross Profit Margin: | 63.19% |
EBIT Margin: | 16.50% |
Net Profit Margin: | 14.95% |
Return on Equity: | 26.18% |
Return on Assets: | 8.64% |
Financial Strength
Liquidity I / Cash Ratio: | 36.39% |
Liquidity II / Quick Ratio: | 98.98% |
Liquidity III / Current Ratio: | 284.44% |
Debt / Equity Ratio: | 202.84% |
Dynam. Debt / Equity Ratio: | 560.57% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |